Clinical Trial Update: A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two doses of sustained-release naltrexone/bupropion against placebo in overweight and obese adults. The study is completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Naltrexone SR/Bupropion SR (Contrave)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21